Jorge Joven
Jorge Joven
Universitat Rovira i Virgili. Hospital de Sant Joan, Reus
Dirección de correo verificada de urv.cat - Página principal
Título
Citado por
Citado por
Año
Hookworm infection
PJ Hotez, S Brooker, JM Bethony, ME Bottazzi, A Loukas, S Xiao
New England Journal of Medicine 351 (8), 799-807, 2004
7982004
Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome
J Joven, C Villabona, E Vilella, L Masana, R Albertí, M Vallés
New England Journal of Medicine 323 (9), 579-584, 1990
3281990
Metformin: multi-faceted protection against cancer
S Del Barco, A Vazquez-Martin, S Cufí, C Oliveras-Ferraros, ...
Oncotarget 2 (12), 896-917, 2011
3112011
The paraoxonases: role in human diseases and methodological difficulties in measurement
J Camps, J Marsillach, J Joven
Critical reviews in clinical laboratory sciences 46 (2), 83-106, 2009
2642009
Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage
N Ferré, J Camps, E Prats, E Vilella, A Paul, L Figuera, J Joven
Clinical chemistry 48 (2), 261-268, 2002
2512002
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile
E Sierra-Filardi, C Nieto, Á Domínguez-Soto, R Barroso, ...
The Journal of Immunology 192 (8), 3858-3867, 2014
2492014
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis
S Cufi, A Vazquez-Martin, C Oliveras-Ferraros, B Martin-Castillo, J Joven, ...
Cell cycle 9 (22), 4461-4468, 2010
2322010
Regulation of Serum Paraoxonase Activity by Genetic, Nutritional, and Lifestyle Factors in the General Population.
N Ferre, J Camps, J Fernandez-Ballart, V Arija, MM Murphy, S Ceruelo, ...
Clinical Chemistry-International Journal of Laboratory Medicine and …, 2003
2092003
Lipoprotein heterogeneity in end-stage renal disease
J Joven, E Vilella, S Ahmad, MC Cheung, JD Brunzell
Kidney international 43 (2), 410-418, 1993
188*1993
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells
J MENENDEZ, J Joven, S Cufí, B Corominas-Faja, C Oliveras-Ferraros, ...
Cell cycle 12 (8), 1166-1179, 2013
182*2013
Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia
J Ribalta, L Figuera, J Fernández-Ballart, E Vilella, M Castro Cabezas, ...
Clinical Chemistry 48 (9), 1597-1600, 2002
1722002
Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.
E Vilella, J Joven, M Fernandez, S Vilaro, JD Brunzell, T Olivecrona, ...
Journal of lipid research 34 (9), 1555-1564, 1993
1651993
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues
J Marsillach, B Mackness, M Mackness, F Riu, R Beltrán, J Joven, ...
Free Radical Biology and Medicine 45 (2), 146-157, 2008
1642008
Interaction of oxidized low density lipoproteins with both apo B, E and scavenger receptors. A model for its production in vitro
E Vilella, J Joven, T Bargalló, PR Turner, L Masana
Clinica chimica acta 210 (1-2), 93-108, 1992
153*1992
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial
JPH van Wijk, EJP de Koning, MC Cabezas, J op't Roodt, J Joven, ...
Annals of internal medicine 143 (5), 337-346, 2005
1502005
Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: a possible role for interleukin-6
M Tous, V Ribas, JC Escolà-Gil, F Blanco-Vaca, L Calpe-Berdiel, B Coll, ...
Cytokine 34 (3-4), 224-232, 2006
147*2006
Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients
JPH van Wijk, EJP de Koning, MC Cabezas, J Joven, J op’t Roodt, ...
Journal of the American College of Cardiology 47 (6), 1117-1123, 2006
1412006
Association study of schizophrenia with polymorphisms at six candidate genes
C Virgos, L Martorell, J Valero, F Civeira, J Joven, A Labad, E Vilella, ...
Schizophrenia research 49 (1-2), 65-71, 2001
1412001
Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele
C Alonso-Villaverde, B Coll, S Parra, M Montero, N Calvo, M Tous, ...
Circulation 110 (15), 2204-2209, 2004
1392004
Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor‐based antiretroviral therapy
B Coll, C Alonso‐Villaverde, S Parra, A Rabassa, L Martorell, J Joven, ...
HIV medicine 7 (6), 356-360, 2006
138*2006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20